Literature DB >> 17035608

Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action.

Allison A Eddy1, Agnes B Fogo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17035608     DOI： 10.1681/ASN.2006050503

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  96 in total

Review 1.  TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.

Authors:  Rohan Samarakoon; Jessica M Overstreet; Stephen P Higgins; Paul J Higgins
Journal:  Cell Tissue Res       Date:  2011-06-04       Impact factor: 5.249

2.  Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease.

Authors:  Jesús M López-Guisa; Allen C Rassa; Xiaohe Cai; Sarah J Collins; Allison A Eddy
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

3.  Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria.

Authors:  Dan Wang; Chunsun Dai; Yingjian Li; Youhua Liu
Journal:  Kidney Int       Date:  2011-08-10       Impact factor: 10.612

Review 4.  Modulation of glomerulosclerosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

5.  Protease nexin-1, tPA, and PAI-1 are upregulated in cryoglobulinemic membranoproliferative glomerulonephritis.

Authors:  Sekiko Taneda; Kelly L Hudkins; Anja S Mühlfeld; Jolanta Kowalewska; Jeffrey W Pippin; Stuart J Shankland; Charles E Alpers
Journal:  J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 10.121

6.  Uridine triphosphate (UTP) induces profibrotic responses in cardiac fibroblasts by activation of P2Y2 receptors.

Authors:  Oscar O Braun; David Lu; Nakon Aroonsakool; Paul A Insel
Journal:  J Mol Cell Cardiol       Date:  2010-05-13       Impact factor: 5.000

7.  Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis.

Authors:  Sha Hao; Weichun He; Yingjian Li; Hong Ding; Yayi Hou; Jing Nie; Fan Fan Hou; Michael Kahn; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2011-08-04       Impact factor: 10.121

8.  Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressure.

Authors:  Steven T Haller; Sivarajan Kumarasamy; David A Folt; Leah M Wuescher; Stanislaw Stepkowski; Manish Karamchandani; Harshal Waghulde; Blair Mell; Muhammad Chaudhry; Kyle Maxwell; Siddhi Upadhyaya; Christopher A Drummond; Jiang Tian; Wanda E Filipiak; Thomas L Saunders; Joseph I Shapiro; Bina Joe; Christopher J Cooper
Journal:  Kidney Int       Date:  2016-09-28       Impact factor: 10.612

Review 9.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

Review 10.  TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities.

Authors:  Rohan Samarakoon; Jessica M Overstreet; Paul J Higgins
Journal:  Cell Signal       Date:  2012-10-11       Impact factor: 4.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.